Roche Molecular Systems Investor Relations Salaries in Wilmington, DE | Comparably
Roche Molecular Systems, Inc., a molecular diagnostics company, develops and commercializes diagnostic and blood screening tests based on read more
EMPLOYEE
PARTICIPANTS
15
TOTAL
RATINGS
176

Roche Molecular Systems Investor Relations Salaries in Wilmington, DE

The average Roche Molecular Systems Investor Relations in Wilmington, DE earns an estimated $57,953 annually. Roche Molecular Systems' Investor Relations compensation is $23,978 less than the US average for a Investor Relations.

In Wilmington, DE, The Communications Department at Roche Molecular Systems earns $10,927 more on average than the Product Department.

Last updated a year ago.

$35k
$47k
$63k
$70k
$109k
$139k
$168k
$57,953
Average Compensation
$57,953
avg. base

Investor Relations Salaries at Roche Molecular Systems

* estimated salary

Compensation at Roche Molecular Systems by Department

In Wilmington, DE, The Communications Department averages $10,927 more than the Product Department, and $431 less than the Enterprise Risk Department

Enterprise Risk
$186,671 Avg. total comp.
+$431
Communications
$186,240 Avg. total comp.
Product
$175,313 Avg. total comp.
-$11k

Investor Relations Compensation by Gender (All Companies)

The average female Investor Relations at companies similar size to Roche Molecular Systems reported making $155,000, while the average male Investor Relations at similar sized companies reported making $50,000.

How Investor Relations at Roche Molecular Systems Rate Their Compensation

The majority of Investor Relations at Roche Molecular Systems believe they're compensated fairly. 100% of Investor Relations at Roche Molecular Systems say they receive annual bonuses, and the majority (60%) are satisfied with their benefits. See more compensation ratings at Roche Molecular Systems

×
Rate your company